HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MCM10
minichromosome maintenance 10 replication initiation factor
Chromosome 10 Β· 10p13
NCBI Gene: 55388Ensembl: ENSG00000065328.18HGNC: HGNC:18043UniProt: Q7L590
112PubMed Papers
21Diseases
0Drugs
4Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
DNA replication initiationDNA damage responsenucleolusprotein bindingimmunodeficiency 80 with or without congenital cardiomyopathyAlzheimer diseasemultiple sclerosisneurodegenerative disease
✦AI Summary

MCM10 is an essential replication initiation factor that coordinates DNA replication machinery assembly and function 1. It acts as a non-enzymatic scaffold protein that brings together the MCM2-7 helicase complex and DNA polymerase alpha/primase to initiate DNA replication, while binding both double-stranded and single-stranded DNA 1. MCM10 plays multifaceted roles beyond initiation: it stabilizes replication forks, coordinates replisome assembly, and regulates replication elongation and termination 2. The protein prevents DNA damage during replication by interacting with BRCA2 to suppress PRIMPOL-mediated repriming and gap formation 3, and assists nucleosome assembly through histone interactions 2. MCM10 dysfunction causes genomic instability. Disruption leads to altered replication timing, initiation site gains/losses, and DNA damage accumulation 2. Loss-of-function mutations cause immunodeficiency 80 with or without congenital cardiomyopathy, a rare human disease. Conversely, MCM10 overexpression associates with increased cancer aggressiveness across multiple cancer types 2. High MCM10 expression independently predicts poor outcomes in hepatocellular carcinoma and correlates with sorafenib resistance and cancer stemness 45. MCM10 knockdown reduces cancer cell proliferation, migration, and invasion in glioblastoma and other malignancies 62, positioning MCM10 as both a prognostic biomarker and potential therapeutic target for cancer treatment.

Sources cited
1
MCM10's multifaceted roles in DNA replication initiation, elongation, termination, fork stability, and genome integrity; overexpression in cancers; effects of knockdown on cancer cell phenotypes
PMID: 39240414
2
MCM10 is essential replication factor required for Cdc45:Mcm2-7:GINS helicase activation; acts as non-enzymatic oligomeric scaffold; binds ds and ssDNA; interacts with DNA pol-Ξ± and PCNA
PMID: 24662891
3
BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and ssDNA gap formation after DNA damage
PMID: 34645815
4
High MCM10 expression correlates with poor HCC patient outcomes and is an independent prognosticator; improves prognostic accuracy when incorporated into multivariate models
PMID: 34350781
5
MCM10 knockdown impairs glioblastoma cell proliferation, migration, and invasion; involved in IGF-1 signaling pathway and tumorigenesis regulation
PMID: 32030558
6
MCM10 promotes cancer stemness and sorafenib resistance in HCC; MCM10 knockout restores sorafenib sensitivity
PMID: 40750706
Disease Associationsβ“˜21
immunodeficiency 80 with or without congenital cardiomyopathyOpen Targets
0.65Moderate
Alzheimer diseaseOpen Targets
0.46Moderate
lysosomal storage diseaseOpen Targets
0.46Moderate
multiple sclerosisOpen Targets
0.46Moderate
neurodegenerative diseaseOpen Targets
0.46Moderate
Parkinson diseaseOpen Targets
0.46Moderate
exostosisOpen Targets
0.28Weak
neuroendocrine neoplasmOpen Targets
0.27Weak
neoplasmOpen Targets
0.10Weak
breast cancerOpen Targets
0.10Weak
hepatocellular carcinomaOpen Targets
0.10Suggestive
cancerOpen Targets
0.10Suggestive
esophageal squamous cell carcinomaOpen Targets
0.09Suggestive
gliomaOpen Targets
0.08Suggestive
posterior cortical atrophyOpen Targets
0.08Suggestive
cervical cancerOpen Targets
0.08Suggestive
adrenal cortex carcinomaOpen Targets
0.07Suggestive
lung adenocarcinomaOpen Targets
0.07Suggestive
isolated asymptomatic elevation of creatine phosphokinaseOpen Targets
0.06Suggestive
renal pelvis/ureter urothelial carcinomaOpen Targets
0.06Suggestive
Immunodeficiency 80 with or without congenital cardiomyopathyUniProt
Pathogenic Variants4
NM_018518.5(MCM10):c.236del (p.Gly79fs)Pathogenic
Immunodeficiency 80 with or without congenital cardiomyopathy|Fetal Cardiomyopathy
β˜…β˜†β˜†β˜†2023β†’ Residue 79
NM_018518.5(MCM10):c.764+5G>APathogenic
Immunodeficiency 80 with or without congenital cardiomyopathy|Fetal Cardiomyopathy
β˜…β˜†β˜†β˜†2023
NM_018518.5(MCM10):c.1276C>T (p.Arg426Cys)Pathogenic
Immunodeficiency 80 with or without congenital cardiomyopathy
β˜†β˜†β˜†β˜†2021β†’ Residue 426
NM_018518.5(MCM10):c.1744C>T (p.Arg582Ter)Pathogenic
Immunodeficiency 80 with or without congenital cardiomyopathy
β˜†β˜†β˜†β˜†2021β†’ Residue 582
View on ClinVar β†—
Related Genes
CDK2Protein interaction100%CCNA2Protein interaction100%CDT1Protein interaction100%CDC6Protein interaction100%CDC25AProtein interaction100%CDK6Protein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
48%
Lung
5%
Ovary
2%
Liver
2%
Heart
1%
Gene Interaction Network
Click a node to explore
MCM10CDK2CCNA2CDT1CDC6CDC25ACDK6
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q7L590
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.94LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.77 [0.64–0.94]
RankingsWhere MCM10 stands among ~20K protein-coding genes
  • #4,235of 20,598
    Most Researched112 Β· top quartile
  • #3,732of 5,498
    Most Pathogenic Variants4
  • #8,719of 17,882
    Most Constrained (LOEUF)0.94
Genes detectedMCM10
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice.
PMID: 33177522
Nat Commun Β· 2020
1.00
2
Multifaceted role of the DNA replication protein MCM10 in maintaining genome stability and its implication in human diseases.
PMID: 39240414
Cancer Metastasis Rev Β· 2024
0.90
3
An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B Ξ±1/2 shedding.
PMID: 39999840
Cell Rep Med Β· 2025
0.80
4
BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage.
PMID: 34645815
Nat Commun Β· 2021
0.70
5
Prognostic significance and function of
PMID: 34350781
Future Oncol Β· 2021
0.60